Showing results (451-460 of 556) with videos related to

Sort By:
Pageof 56
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 7, 1999
A novel bioassay for the determination of neutralizing antibodies to IFN-beta1bE Pungor, J G Files, J D Gabe, et al.
European Heart Journal|November 1, 2001
Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-upB J Rensing, J Vos, P C Smits, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 21, 2003
Sonotherapy, antirestenotic therapeutic ultrasound in coronary arteries: the first clinical experienceE Regar, A Thury, W J van der Giessen, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 28, 2012
The vascular disrupting agent STA-9584 exhibits potent antitumor activity by selectively targeting microvasculature at both the center and periphery of tumorsKevin P Foley, Dan Zhou, Chris Borella, et al.
Plos One|May 3, 2011
Multifaceted intervention by the Hsp90 inhibitor ganetespib (STA-9090) in cancer cells with activated JAK/STAT signalingDavid A Proia, Kevin P Foley, Tim Korbut, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 28, 2020
MALT1 Protease Plays a Dual Role in the Allergic Response by Acting in Both Mast Cells and Endothelial CellsDanielle N Alfano, Linda R Klei, Hanna B Klei, et al.
The British Journal of Dermatology|June 9, 2021
Five-year maintenance of clinical response and health-related quality of life improvements in patients with moderate-to-severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2K Reich, K B Gordon, B E Strober, et al.
Circulation|January 4, 2001
Radioactive stents delay but do not prevent in-stent neointimal hyperplasiaI P Kay, A J Wardeh, K Kozuma, et al.
Journal of the American College of Cardiology|January 15, 2002
Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: results of the randomized investigation by the Thoraxcenter of antisense DNA using local delivery and IVUS after coronary stenting (ITALICS) trialMichael J B Kutryk, David P Foley, Marcel van den Brand, et al.
Physiological Reports|March 5, 2022
Life-long exercise training and inherited aerobic endurance capacity produce converging gut microbiome signatures in rodentsFernando F Anhê, Soumaya Zlitni, Nicole G Barra, et al.
Pageof 56